Tsukuba, Japan

Hiroe Minami


Average Co-Inventor Count = 11.6

ph-index = 4

Forward Citations = 156(Granted Patents)


Location History:

  • Ibaraki, JP (2005)
  • Tsukuba, JP (2006 - 2011)

Company Filing History:


Years Active: 2005-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hiroe Minami: Innovator in Nitrogen-Containing Heterocyclic Compounds

Introduction

Hiroe Minami is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of nitrogen-containing heterocyclic compounds. With a total of 4 patents to his name, Minami's work has implications for various therapeutic applications.

Latest Patents

Minami's latest patents focus on nitrogen-containing heterocyclic compounds and medicines derived from them. These compounds are represented by complex general formulas, which include various structural components such as single bonds, Calkylene groups, and optionally substituted phenyl and heterocyclic groups. His innovative work in this area aims to enhance the efficacy of medicinal compounds, providing new avenues for treatment.

Career Highlights

Throughout his career, Hiroe Minami has worked with prominent organizations, including Eisai Company, Limited and Eisai R&D Management Co., Ltd. His experience in these companies has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Minami has collaborated with notable colleagues, including Fumihiro Ozaki and Mutsuko Ono. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Hiroe Minami's contributions to the field of medicinal chemistry through his patents on nitrogen-containing heterocyclic compounds highlight his role as a significant inventor. His work continues to influence the development of new medicines and therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…